| |
 |
|
Class Information
Number: 514/295
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered consisting of one nitrogen and five carbon atoms > Polycyclo ring system having the six-membered hetero ring as one of the cyclos > Tricyclo ring system having the six-membered hetero ring as one of the cyclos > Two of the cyclos share at least three ring carbons (i.e., bridged) (e.g., benzomorphans, etc.)
Description: Subject matter wherein two cyclos of the polycyclo ring system share at least three ring carbons.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7612087 |
Heterocyclic compounds as inhibitors of beta-lactamases |
Nov. 3, 2009 |
| 7557119 |
Large substituent, non-phenolic opioids |
Jul. 7, 2009 |
| 7205300 |
Aryl fused azapolycyclic compounds |
Apr. 17, 2007 |
| 7144882 |
Aryl fused azapolycyclic compounds |
Dec. 5, 2006 |
| 7041674 |
Carbamic acid esters with anticholinergic activity |
May. 9, 2006 |
| 6982271 |
Tropane analogs |
Jan. 3, 2006 |
| 6964969 |
Composition and method for treating impaired or deteriorating neurological function |
Nov. 15, 2005 |
| 6939867 |
.beta.3 agonists and uses thereof |
Sep. 6, 2005 |
| 6887884 |
Aryl fused azapolycyclic compounds |
May. 3, 2005 |
| 6878700 |
Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
Apr. 12, 2005 |
| 6867203 |
Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
Mar. 15, 2005 |
| 6828311 |
Formulation for the parenteral application of a sodium channel blocker |
Dec. 7, 2004 |
| 6784186 |
Therapeutic compounds |
Aug. 31, 2004 |
| 6750224 |
Antibacterial optically pure benzoquinolizine carboxylic acids, processes, compositions and methods of treatment |
Jun. 15, 2004 |
| RE38460 |
Huperzine A derivatives, their preparation and their use |
Mar. 9, 2004 |
| 6683089 |
N-allyoxyethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-ols |
Jan. 27, 2004 |
| 6605610 |
Aryl fused azapolycyclic compounds |
Aug. 12, 2003 |
| 6486169 |
Botanical drug for treatment and prevention of alzhimer's disease |
Nov. 26, 2002 |
| 6455538 |
1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocin-10-ols |
Sep. 24, 2002 |
| 6451806 |
Methods and compositions involving opioids and antagonists thereof |
Sep. 17, 2002 |
| 6410550 |
Aryl fused azapolycyclic compounds |
Jun. 25, 2002 |
| 6387921 |
Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and their use as pharmaceutical compositions |
May. 14, 2002 |
| 6369052 |
Combination of huperzine and nicotinic compounds as a neuroprotective agent |
Apr. 9, 2002 |
| 6355652 |
Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and their use as pharmaceutical compositions |
Mar. 12, 2002 |
| 6255302 |
1,4-piperazine derivatives |
Jul. 3, 2001 |
| 6251916 |
Muscarinic agonists and antagonists |
Jun. 26, 2001 |
| 6245777 |
N-(5-phenyl-tetrahydrofuranyl)methyl- and N-(6-phenyl-tetrahydropyranyl)methyl-substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols |
Jun. 12, 2001 |
| 6218376 |
Uracil compounds as P2-purinoreceptor 7-transmembrane G-protein coupled receptor antagonists |
Apr. 17, 2001 |
| 6191139 |
Medical use for tachykinin antagonists |
Feb. 20, 2001 |
| 6159986 |
Compounds and therapy for resisting memory loss in humans |
Dec. 12, 2000 |
| 6124312 |
Heterocyclic compounds |
Sep. 26, 2000 |
| 6121269 |
Reduction of hair growth |
Sep. 19, 2000 |
| 5990104 |
Polycyclic alcaloid-derivatives as NMDA-receptor antagonists |
Nov. 23, 1999 |
| 5929084 |
Huperzine A derivatives, their preparation and their use |
Jul. 27, 1999 |
| 5925649 |
Ascomycins |
Jul. 20, 1999 |
| 5821248 |
Quinuclidine derivatives |
Oct. 13, 1998 |
| 5731318 |
Benzomorphan derivatives |
Mar. 24, 1998 |
| 5650406 |
Adamantane derivative, process for producing the same, and use thereof |
Jul. 22, 1997 |
| 5594002 |
Benzazabicyclic carbamates as novel cholinesterase inhibitors |
Jan. 14, 1997 |
| 5587381 |
Method for terminating methadone maintenance through extinction of the opiate-taking responses |
Dec. 24, 1996 |
| 5580891 |
N-[heteroaryl-1-pyrrolidinyl)alkyl]-2-benoxazolinones and related compounds and their therapeutic utility |
Dec. 3, 1996 |
| 5561128 |
N-[(4-(hete roaryl)-1-piperidinyl)alkyl]-10,11-dihydro-5H-dibenz[B,F]azepines and related compounds and their therapeutic utility |
Oct. 1, 1996 |
| 5547960 |
C-10 analogs of huperzine a |
Aug. 20, 1996 |
| 5446049 |
Azanoradamantanes for treatment of conditions responsive to 5-HT agonists and/or antagonists |
Aug. 29, 1995 |
| 5354758 |
Benzomorphans useful as NMDA receptor antagonists |
Oct. 11, 1994 |
| 5350756 |
Use of a cytochrome oxidase inhibitor to increase the cough-suppressing activity of dextromorphan |
Sep. 27, 1994 |
| 5246940 |
Substituted N-biphenylyl lactams |
Sep. 21, 1993 |
| 5240935 |
Substituted 2-azabicyclo[2.2.2]octane derivatives and compositions and method of use thereof |
Aug. 31, 1993 |
| 5234924 |
Benzothiazine and benzothiazole compounds useful as analgesics |
Aug. 10, 1993 |
| 5212185 |
Piperidinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
May. 18, 1993 |
|
|
|
